Tofacitinib for the Treatment of Lichen Planopilaris: A Case Series

    September 2018 in “ Dermatologic therapy ”
    Christine C. Yang, Trisha Khanna, B. Sallee, Angela M. Christiano, Lindsey Bordone
    Image of study
    TLDR Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.
    In this case series, 10 patients with recalcitrant lichen planopilaris (LPP) were treated with oral tofacitinib, a Janus kinase (JAK) inhibitor, at doses of 5 mg twice or three times daily for 2–19 months. The treatment was administered either as monotherapy or in combination with other therapies. Eight patients showed clinical improvement, with significant reductions in the LPP Activity Index (LPPAI) from an average of 6.22 before treatment to 3.08 after treatment (p = .0014), indicating a reduction in LPPAI ranging from 30 to 94%. One patient experienced a 10-pound weight gain, but no other adverse effects were reported. The study concluded that oral tofacitinib could lead to measurable improvement in recalcitrant LPP.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results

    Related Community Posts Join

    6 / 12 results

      community can someone help me identify these pls

      in Treatment 3 months ago
      The user is experiencing diffuse thinning and inflammation despite using 2.5mg dutasteride daily, ciclopirox, and ketoconazole shampoos. They are considering treatments like hydroxychloroquine and JAK inhibitors due to suspected scarring alopecia and have faced challenges in obtaining a scalp biopsy.

      community IGE Hair Loss and Miniaturization

      in Chat  3 upvotes 10 months ago
      A 23-year-old male is experiencing diffuse hair loss and miniaturization, possibly due to high IGE levels after using tofacitinib. He seeks advice and has not yet consulted a dermatologist.

      community Topical solution recommendation

      in Treatment  2 upvotes 6 months ago
      The user is using finasteride 1mg every other day and seeks a topical solution excluding minoxidil. They are considering various combinations of ingredients like finasteride, dutasteride, and tofacitinib, with options for nourishing oils and other additives.

      community Topical solution recommendation

      in Product  1 upvotes 6 months ago
      The user is using finasteride 1mg every other day and seeks a topical solution to complement it, excluding minoxidil. They are considering various combinations of ingredients like finasteride, dutasteride, and tofacitinib, with options for nourishing oils and other additives.

    Related Research

    1 / 1 results